Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature

Atici S., Soysal A., KARADENİZ CERİT K., Yilmaz S., Aksuc B., KIYAN G., ...Daha Fazla

MEDICAL MYCOLOGY CASE REPORTS, cilt.15, ss.33-35, 2017 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 15
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.mmcr.2017.02.002
  • Dergi Adı: MEDICAL MYCOLOGY CASE REPORTS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.33-35
  • Anahtar Kelimeler: Saccharomyces cerevisiae, Saccharomyces boulardii, Fungemia, Probiotic treatment, Intensive care unit, PATIENT
  • Marmara Üniversitesi Adresli: Evet

Özet

Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing S. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We want to emphasize that physicians should be careful about probiotic usage in critically ill patients.